Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation
- 24 September 2008
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 20 (1-2) , 29-31
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Primer: histopathology of calcineurin-inhibitor toxicity in renal allograftsNature Clinical Practice Nephrology, 2006
- Molecular Comparison of Calcineurin Inhibitor–Induced Fibrogenic Responses in Protocol Renal Transplant BiopsiesJournal of the American Society of Nephrology, 2006
- TGF-β1 Expression in Renal Allograft Rejection and Cyclosporine A ToxicityTransplantation, 2005
- Endothelin‐1 plasma levels and hypertension in cyclosporine‐treated renal transplant patientsClinical Transplantation, 2005
- Epithelial to Mesenchymal Transition in Renal FibrogenesisJournal of the American Society of Nephrology, 2004
- The Natural History of Chronic Allograft NephropathyNew England Journal of Medicine, 2003
- Intracellular Mechanisms of Cyclosporin A–Induced Tubular Cell ApoptosisJournal of the American Society of Nephrology, 2003
- Role of prostanoids and endothelins in the prevention of cyclosporine-induced nephrotoxicityProstaglandins, Leukotrienes and Essential Fatty Acids, 2001
- Does cyclosporin A generate free radicals?Trends in Pharmacological Sciences, 2000
- Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathyKidney International, 1999